Technology | September 19, 2012

Monaco 3.20 improves plan quality, dose conformity and treatment delivery efficiency for VMAT and Agility

Elekta Launches New Version of Monaco Treatment Planning System with Segment Shape Optimization

September 19, 2012 — Elekta recently announced the latest production release of its Monaco treatment planning system, Version 3.20, which offers customers improved VMAT (volumetric modulated arc therapy) planning and delivery support, in addition to support for Elekta's Agility 160-leaf multileaf collimator (MLC). This release promises to create new workflow efficiencies through integrated plan approval and enhanced integration with Mosaiq oncology information system.

The new Segment Shape Optimization is driving improved dose conformity, plan quality and delivery efficiency through its proprietary approach to smoothing and clustering segments then optimizing beam weights and shapes. Powered by the Monte Carlo algorithm, the results are plans that improve sparing of organs-at-risk and dose conformality.

In addition, the release's new contouring tool, EZ Sketch, and Room's Eye View increase workflow efficiency. Support for Agility means that Monaco 3.20 users can achieve a new level of beam-shaping precision and delivery speed.

Staff at Kettering Medical Center in Dayton, Ohio, have been using a pilot version of Monaco 3.20 since June 2012, says Christopher Wennerstrom, MS, DABR, medical physicist at the center. "It has consistently provided excellent tumor coverage while meeting our physicians' very strict OAR tolerances. The new Target Penalty cost function and segment shape optimizer allow us to treat more patients with VMAT than ever before, and even our most complex SBRT [stereotactic body radiotherapy] cases have extremely quick treatment times."

Monaco is a planning solution for IMRT (intensity-modulated radiotherapy), VMAT and SBRT, and features innovative biological cost functions with multi-criterial constrained optimization, a powerful leaf sequence optimizer and a Monte Carlo dose calculation algorithm.

For more information: www.elekta.com/rtp


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Subscribe Now